Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents
Sign Up to like & getrecommendations! Published in 2017 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.23256
Abstract: Overactive bladder (OAB) is highly prevalent particularly among obese patients and significantly impacts quality of life. Anticholinergics are the first‐line treatment. The effect of obesity on medication compliance has not been studied. Our study evaluated… read more here.
Keywords: gender obesity; persistence; overactive bladder; obesity ... See more keywords